Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001679.pdf 0001562180-19-001679.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001680.pdf 0001562180-19-001680.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001677.pdf 0001562180-19-001677.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001675.pdf 0001562180-19-001675.rtf View HTML
February 14, 2019	SC 13G/A	An amendment to the SC 13G filing	0000929638-19-000278.pdf 0000929638-19-000278.rtf 0000929638-19-000278.xls View HTML
February 11, 2019	SC 13G/A	An amendment to the SC 13G filing	0000215457-19-007515.pdf 0000215457-19-007515.rtf View HTML
January 25, 2019	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-19-017081.pdf 0001193125-19-017081.rtf 0001193125-19-017081.xls View HTML
January 11, 2019	SC 13D/A	An amendment to a SC 13D filing	0001193125-19-007484.pdf 0001193125-19-007484.rtf 0001193125-19-007484.xls View HTML
January 10, 2019	SC 13G/A	An amendment to the SC 13G filing	0000215457-19-000127.pdf 0000215457-19-000127.rtf View HTML
January 9, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001567619-19-000883.pdf 0001567619-19-000883.rtf 0001567619-19-000883.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax